---
schema_version: "secwatch.filing_event.v1"
accession: "0000051253-23-000015"
form_type: "8-K"
ticker: "IFF"
cik: "0000051253"
company_name: "INTERNATIONAL FLAVORS & FRAGRANCES INC"
filed_at: "2023-05-08T23:59:59+00:00"
generated_at: "2026-06-15T14:39:05.073415+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# IFF reports Q1 2023: GAAP EPS $(0.04), adj. EPS $0.87; sales flat at $3.03B

## Summary
- Reported net sales $3.03B flat YoY; currency-neutral comparable sales +1% led by Scent and Pharma.
- GAAP EPS $(0.04); adjusted EPS ex amortization $0.87.
- Adjusted operating EBITDA $503M, down 19% comparable currency-neutral; lower volumes and destocking offset pricing.
- Cash from operations $127M; free cash flow -$48M; net debt to credit adjusted EBITDA 4.6x.
- CEO says results in line/ahead of expectations but market conditions remain uncertain.

## SEC filing metadata
- accession: 0000051253-23-000015
- form_type: 8-K
- ticker: IFF
- cik: 0000051253
- company_name: INTERNATIONAL FLAVORS & FRAGRANCES INC
- filed_at: 2023-05-08T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/51253/000005125323000015/0000051253-23-000015-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/51253/000005125323000015/iff-20230508.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000051253-23-000015
- JSON: https://secwatch.observer/filing/0000051253-23-000015.json
- Plain text: https://secwatch.observer/filing/0000051253-23-000015.txt

## Key facts
- Earnings Releases
  INTERNATIONAL FLAVORS & FRAGRANCES INC reported first quarter ended March 31, 2023 results: revenue $3.03 billion, EPS $(0.04).
  - Period: first quarter ended March 31, 2023
  - Revenue: $3.03 billion
  - EPS: $(0.04)
  - Result: reported results
  source text: drive portfolio optimization to generate strong returns for our shareholders.” First Quarter 2023 Consolidated Financial Results • Reported net sales for the first quarter were $3.03 billion, flat versus the prior-year period. On a comparable basis 2 , currency neutral sales increased 1% versus the prior-year period, led by Scent and Pharma Solutions. • Income before
  evidence_url: https://www.sec.gov/Archives/edgar/data/51253/000005125323000015/0000051253-23-000015-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.